Eos

Day-to-day private equity investment decisions sit with the firm's three-decade partnership group — Co-Founders Brian Young and Steven Friedman, and Partner Mark First. Managing Directors Brendan Moore and Adam Gruber lead origination and oversight within defined industry verticals. All three principals have operated together since the firm's founding in 1994, giving Eos one of the most stable decision-making cadres in the lower middle market.

Eos does not publicly disclose its capital structure or whether it raises blind-pool funds, manages separately capitalized vehicles, or invests purely proprietary capital. The firm's website makes no reference to limited partners, fund closes, or fundraising milestones. The opacity is consistent with a firm that prioritizes balance-sheet flexibility over institutional asset-gathering.

Eos has not publicly stated a co-investment policy. The firm's sourcing appears overwhelmingly relationship-driven and self-originated, consistent with a model built on direct control and influence positions in lower-middle-market companies. No public record indicates Eos participates as a passive co-investor alongside unaffiliated general partners.

Eos's sourcing advantage rests on three decades of relationship capital accumulated by Brian Young and Steven Friedman, dating to their tenure at Odyssey Partners and earlier Wall Street roles. The firm's small team and single-office structure favor concentrated origination effort rather than a scaled, multi-channel sourcing machine. The website emphasizes a collaborative approach with management partners, suggesting much deal flow comes through founder- and executive-level networks rather than auction processes.

The firm's investment team covers tech-enabled services, digital transformation, financial services and fintech, supply chain and logistics, energy transition, industrial services, healthcare services, consumer, agribusiness, and distribution. Current Managing Director-level mandates map specifically to these verticals. Eos does not publish a formal exclusion list, but its historical portfolio contains no exposure to biotechnology, pharmaceuticals, commodities extraction, or hardware-heavy deep tech.

Yes. Eos Credit Opportunities — referred to internally as ECO — is a dedicated credit sleeve built to generate stable, predictable, long-term returns in corporate credit. The firm has not disclosed the vehicle's size, duration, or whether it includes direct lending, distressed, or structured credit components. The strategy operates alongside, but structurally separate from, the private equity and public-equities efforts.

Eos's public-equity strategy targets market-leading companies with clear and sustainable pathways for long-term growth. The firm invests in publicly traded securities, implying a liquid, mark-to-market mandate that contrasts with the control-oriented illiquidity of its private equity book. The team does not name a dedicated public-equities portfolio manager on its website, suggesting the strategy may be run collaboratively by the senior partners.